Shareholder loans - 2023 and Greybrook Notes (Details)			12 Months Ended
	Aug. 01, 2023 USD ($) D shares	Feb. 28, 2023 USD ($) D $ / shares shares	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Feb. 03, 2023 USD ($)
Debt Instruments
Face Amount			$ 36,426,638
Gain on loan extinguishment			(14,274)	$ (2,331,917)
Greybrook Health Inc | February 2023 Warrants
Debt Instruments
Number of shares per warrant (in shares) | shares		1
Warrant exercise price (in $ per share) | $ / shares		$ 1.84
Greybrook Health Inc | August 2023 Warrants
Debt Instruments
Number of shares per warrant (in shares) | shares	1
Fair value of warrants	$ 19,728
Related party | Greybrook Health Inc | February 2023 Warrants
Debt Instruments
Number of warrants issued (in shares) | shares		135,870
Number of shares per warrant (in shares) | shares		1
Warrant exercise price (in $ per share) | $ / shares		$ 1.84
Fair value of warrants		$ 63,587
February 2023 and August 2023 Notes
Debt Instruments
Gain on loan extinguishment			(39,822)
Carrying amount			0	0
February 2023 and August 2023 Notes | Greybrook Health Inc
Debt Instruments
Total deferred financing costs			109,132
Amortization of deferred financing costs			$ 7,656	$ 0
February 2023 Notes
Debt Instruments
Face Amount					$ 690,000
February 2023 Notes | Greybrook Health Inc
Debt Instruments
Face Amount		1,000,000
February 2023 Notes | Significant Shareholder | Greybrook Health Inc
Debt Instruments
Conversion amount - Maximum		$ 1,000,000
Minimum conversion price percentage (in %)		85.00%
Volume weighted average trading days | D		5
August 2023 Notes | Greybrook Health Inc
Debt Instruments
Face Amount	$ 1,000,000
Minimum conversion price percentage (in %)	85.00%
Volume weighted average trading days | D	5
Number of warrants issued (in shares) | shares	250,000